These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nuclear medicine annual external occupational dose distribution: Rio de Janeiro, Brazil, year 2005. Mauricio CL; Lima AL; da Silva HL; Souza-Santos D; Silva CR Radiat Prot Dosimetry; 2011 Mar; 144(1-4):510-4. PubMed ID: 21051433 [TBL] [Abstract][Full Text] [Related]
23. Criteria for the release of individuals administered radioactive materials--NRC. Final rule. Fed Regist; 1997 Jan; 62(19):4120-33. PubMed ID: 10164806 [TBL] [Abstract][Full Text] [Related]
24. [Nuclear medicine entangled by administrative regulations]. Meyer GJ Nuklearmedizin; 2013; 52(2):N11-5. PubMed ID: 23503760 [TBL] [Abstract][Full Text] [Related]
25. Global view on radiation protection in medicine. Vano E Radiat Prot Dosimetry; 2011 Sep; 147(1-2):3-7. PubMed ID: 21725079 [TBL] [Abstract][Full Text] [Related]
26. [PET and diagnostic technology evaluation in a global clinical process. DGN's point of view]. Kotzerke J; Dietlein M; Grünwald F; Bockisch A Nuklearmedizin; 2010; 49(1):6-12. PubMed ID: 20087534 [TBL] [Abstract][Full Text] [Related]
27. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Zanzonico P; Dauer L; St Germain J Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690 [TBL] [Abstract][Full Text] [Related]
29. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]
30. Dose rates in nuclear medicine and the effectiveness of lead aprons: updating the department's knowledge on old and new procedures. Young AM Nucl Med Commun; 2013 Mar; 34(3):254-64. PubMed ID: 23353888 [TBL] [Abstract][Full Text] [Related]
31. Extremity exposure in nuclear medicine: preliminary results of a European study. Sans Merce M; Ruiz N; Barth I; Carnicer A; Donadille L; Ferrari P; Fulop M; Ginjaume M; Gualdrini G; Krim S; Mariotti F; Ortega X; Rimpler A; Vanhavere F; Baechler S Radiat Prot Dosimetry; 2011 Mar; 144(1-4):515-20. PubMed ID: 21233097 [TBL] [Abstract][Full Text] [Related]
32. [Recommendation of the working group commissioned by the French Nuclear Safety Authority on stereotactic radiation therapy]. Gérard JP; Aubert B; Buchheit I; Derreumaux S; Lartigau E; Latorzeff I; Lisbona A; Marinello G; Ménéchal P; Porcheron D; Zeghari Squalli N; Isambert A; Cancer Radiother; 2012 Jun; 16 Suppl():S5-9. PubMed ID: 22578900 [TBL] [Abstract][Full Text] [Related]
33. [Agencies for radiation protection in Germany, Europe and worldwide. Responsibilities and relations between]. Müller WU Nuklearmedizin; 2013; 52(2):N17-20. PubMed ID: 23503761 [TBL] [Abstract][Full Text] [Related]
34. [Procedures and methods of benefit assessments for medicines in Germany]. Bekkering GE; Kleijnen J Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813 [TBL] [Abstract][Full Text] [Related]
35. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1-statement of the issue and a review of available resources. Fahey FH; Bom HH; Chiti A; Choi YY; Huang G; Lassmann M; Laurin N; Mut F; Nuñez-Miller R; O'Keeffe D; Pradhan P; Scott AM; Song S; Soni N; Uchiyama M; Vargas L J Nucl Med; 2015 Apr; 56(4):646-51. PubMed ID: 25766899 [TBL] [Abstract][Full Text] [Related]
36. EUTEMPE-RX, an EC supported FP7 project for the training and education of medical physics experts in radiology. Bosmans H; Bliznakova K; Padovani R; Christofides S; Van Peteghem N; Tsapaki V; Caruana CJ; Vassileva J Radiat Prot Dosimetry; 2015 Jul; 165(1-4):518-22. PubMed ID: 25969526 [TBL] [Abstract][Full Text] [Related]
37. Quality assurance in CT with the Belgian protocol and the new European acceptability criteria. Bosmans H; Lemmens K; Malone J; Oyen R Radiat Prot Dosimetry; 2013 Feb; 153(2):197-205. PubMed ID: 23233502 [TBL] [Abstract][Full Text] [Related]
38. Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. Basu S; Alavi A J Nucl Med; 2008 Oct; 49(10):17N-21N, 37N. PubMed ID: 18832112 [No Abstract] [Full Text] [Related]
39. [Potential radiation hazard in nuclear medicine]. Guilabert N; Ricard M; Chamoulaud K; Mazelier C; Schlumberger M Rev Prat; 2015 Jan; 65(1):83-4. PubMed ID: 25842441 [TBL] [Abstract][Full Text] [Related]
40. Radiopharmaceutical research and production in Brazil: a 30-year history of participation in the nuclear medicine scenario. Santos-Oliveira R; Antunes LJ J Nucl Med Technol; 2011 Sep; 39(3):237-9. PubMed ID: 21795367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]